Molecular insights into the interaction between human nicotinamide phosphoribosyltransferase and Toll-like receptor 4.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
03 2022
Historique:
received: 10 09 2021
revised: 23 01 2022
accepted: 25 01 2022
pubmed: 6 2 2022
medline: 16 4 2022
entrez: 5 2 2022
Statut: ppublish

Résumé

The secreted form of the enzyme nicotinamide phosphoribosyltransferase (NAMPT), which catalyzes a key reaction in intracellular NAD biosynthesis, acts as a damage-associated molecular pattern triggering Toll-like receptor 4 (TLR4)-mediated inflammatory responses. However, the precise mechanism of interaction is unclear. Using an integrated approach combining bioinformatics and functional and structural analyses, we investigated the interaction between NAMPT and TLR4 at the molecular level. Starting from previous evidence that the bacterial ortholog of NAMPT cannot elicit the inflammatory response, despite a high degree of structural conservation, two positively charged areas unique to the human enzyme (the α1-α2 and β1-β2 loops) were identified as likely candidates for TLR4 binding. However, alanine substitution of the positively charged residues within these loops did not affect either the oligomeric state or the catalytic efficiency of the enzyme. The kinetics of the binding of wildtype and mutated NAMPT to biosensor-tethered TLR4 was analyzed. We found that mutations in the α1-α2 loop strongly decreased the association rate, increasing the K

Identifiants

pubmed: 35120922
pii: S0021-9258(22)00109-0
doi: 10.1016/j.jbc.2022.101669
pmc: PMC8892085
pii:
doi:

Substances chimiques

Cytokines 0
NF-kappa B 0
TLR4 protein, human 0
Toll-Like Receptor 4 0
NAD 0U46U6E8UK
Nicotinamide Phosphoribosyltransferase EC 2.4.2.12
nicotinamide phosphoribosyltransferase, human EC 2.4.2.12

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101669

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.

Auteurs

Massimiliano Gasparrini (M)

Department of Agricultural, Food and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy.

Francesca Mazzola (F)

Department of Clinical Sciences, Polytechnic University of Marche, Ancona, Italy.

Massimiliano Cuccioloni (M)

School of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.

Leonardo Sorci (L)

Division of Bioinformatics and Biochemistry, Department of Materials, Environmental Sciences and Urban Planning, Polytechnic University of Marche, Ancona, Italy.

Valentina Audrito (V)

Department of Medical Sciences, University of Turin, Turin, Italy.

Federica Zamporlini (F)

Department of Agricultural, Food and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy.

Carlo Fortunato (C)

Department of Agricultural, Food and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy.

Adolfo Amici (A)

Department of Clinical Sciences, Polytechnic University of Marche, Ancona, Italy.

Michele Cianci (M)

Department of Agricultural, Food and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy.

Silvia Deaglio (S)

Department of Medical Sciences, University of Turin, Turin, Italy.

Mauro Angeletti (M)

School of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.

Nadia Raffaelli (N)

Department of Agricultural, Food and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy. Electronic address: n.raffaelli@staff.univpm.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH